Rapport Therapeutics, Inc. (RAPP) Stock News & Chart | StockAdder

(RAPP)

Rapport Therapeutics, Inc.

Stock chart and latest news for Rapport Therapeutics, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Rapport Therapeutics, Inc. News

PRO

Insider Sell: Krishnaswamy Yeleswaram Sells Shares of Rapport Th

Apr 15, 2026 simplywall.st

How Investors May Respond To Rapport Therapeutics (RAPP) Phase 2a RAP-219 Data Spotlight At AAN 2026

Apr 11, 2026 Stock Titan

10b5-1 insider sales reported for RAPP (NASDAQ: RAPP) in March–April 2026

Apr 13, 2026 Yahoo Finance

All You Need to Know About Rapport Therapeutics, Inc. (RAPP) Rating Upgrade to Buy

Mar 26, 2026 TradingView — Track All Markets

RAPP Stock Price and Chart — NASDAQ:RAPP

Feb 18, 2026 Investing.com South Africa

Rapport Therapeutics’ Yeleswaram sells $12.6k in stock By Investing.com

Apr 9, 2026 Stock Titan

Rapport Therapeutics (RAPP) CDO sells small block of shares

Apr 9, 2026 Yahoo Finance

Assessing Rapport Therapeutics (RAPP) Valuation After Recent Share Price Strength

Jan 8, 2026 simplywall.st

A Look At Rapport Therapeutics (RAPP) Valuation As RAP-219 Advances Toward Phase 2a Data And Phase 3 Plans

Apr 6, 2026 Investing.com

Rapport Therapeutics COO Gault sells $281k in stock

Mar 31, 2026 Stock Titan

Rapport's new 8-week seizure data heads to a major neurology meeting

Apr 1, 2026 Yahoo Finance

Rapport Therapeutics (RAPP) Valuation Check After a 60% Year-to-Date Share Price Surge